×
About 2,148 results

ALLMedicine™ Implantable Cardioverter-defibrillators Center

Research & Reviews  689 results

Risk Stratification of VT / VF After Myocardial Infarction Based on Cardiac MRI 2
https://clinicaltrials.gov/ct2/show/NCT05226234

Aug 3rd, 2022 - Implantable cardioverter-defibrillators (ICD) are currently recommended (ESC guidelines 2015) for the primary prevention of sudden cardiac death (SCD) in patients with a remote myocardial infarction (MI) and a low (≤35%) left ventricular ejection ...

Impact of PREVENTIVE Substrate Ablation of Coronary Chronic Total Occlusion on Implantable cardioVerTer-Defibrillator Interventions
https://clinicaltrials.gov/ct2/show/NCT03421834

Jul 26th, 2022 - Implantable cardioverter-defibrillators (ICDs) improve survival among patients with ischemic heart failure (HF) who have not previously had a sustained ventricular arrhythmia. However, ICD shocks that terminate ventricular tachycardia (VT) are ass...

Hemodynamic Response and Safety of Vasodilator Stress Cardiovascular Magnetic Resonance...
https://doi.org/10.1111/jce.15630
Journal of Cardiovascular Electrophysiology; Miller L, Airapetov S et. al.

Jul 18th, 2022 - Vasodilator stress cardiovascular magnetic resonance (CMR) is a powerful diagnostic modality, but data toward its use in patients with permanent pacemakers (PPMs) or implantable cardioverter-defibrillators (ICDs) is limited. Patients with ICDs (>1...

A Multicenter Trial of a Shared DECision Support Intervention for Patients Offered Implantable Cardioverter-DEfibrillators
https://clinicaltrials.gov/ct2/show/NCT03374891

Jul 8th, 2022 - The investigators propose the DECIDE-ICD trial: a type II effectiveness implementation hybrid trial of the investigators ICD PtDAs. The Investigators will use a 6-site stepped-wedge design, with implementation guided by normalization process theor...

Posttraumatic stress disorder in pediatric patients with implantable cardioverter-defib...
https://doi.org/10.1016/j.hrthm.2022.06.025
Heart Rhythm; Schneider LM, Wong JJ et. al.

Jul 1st, 2022 - An implantable cardioverter-defibrillator (ICD) in the pediatric patient (and the precipitating events that led to ICD placement) can be traumatic for patients and their families and may lead to posttraumatic stress disorder (PTSD). This study aim...

see more →

Clinicaltrials.gov  40 results

Risk Stratification of VT / VF After Myocardial Infarction Based on Cardiac MRI 2
https://clinicaltrials.gov/ct2/show/NCT05226234

Aug 3rd, 2022 - Implantable cardioverter-defibrillators (ICD) are currently recommended (ESC guidelines 2015) for the primary prevention of sudden cardiac death (SCD) in patients with a remote myocardial infarction (MI) and a low (≤35%) left ventricular ejection ...

Impact of PREVENTIVE Substrate Ablation of Coronary Chronic Total Occlusion on Implantable cardioVerTer-Defibrillator Interventions
https://clinicaltrials.gov/ct2/show/NCT03421834

Jul 26th, 2022 - Implantable cardioverter-defibrillators (ICDs) improve survival among patients with ischemic heart failure (HF) who have not previously had a sustained ventricular arrhythmia. However, ICD shocks that terminate ventricular tachycardia (VT) are ass...

A Multicenter Trial of a Shared DECision Support Intervention for Patients Offered Implantable Cardioverter-DEfibrillators
https://clinicaltrials.gov/ct2/show/NCT03374891

Jul 8th, 2022 - The investigators propose the DECIDE-ICD trial: a type II effectiveness implementation hybrid trial of the investigators ICD PtDAs. The Investigators will use a 6-site stepped-wedge design, with implementation guided by normalization process theor...

Stereotactic Arrhythmia Radioablation for Ventricular Tachycardia (StAR-VT)
https://clinicaltrials.gov/ct2/show/NCT05258422

Jun 3rd, 2022 - Ventricular tachycardia (VT) is a potentially life-threatening arrhythmia characterized by electrical re-entry within patches of heterogeneous myocardial fibrosis leading to sustained consecutive ventricular beats at a rate > 100 per minute. VT is...

S-ICD French Cohort Study (HONEST)
https://clinicaltrials.gov/ct2/show/NCT05302115

May 12th, 2022 - Implantable cardioverter-defibrillators have been proven to be effective in the prevention of sudden cardiac death in high-risk patients. However, it is well acknowledged that such a strategy could be optimised, especially through new technologies...

see more →

News  129 results

Jul 22, 2022 This Week in Cardiology Podcast
https://www.medscape.com/viewarticle/977668

Jul 22nd, 2022 - Please note that the text below is not a full transcript and has not been copyedited. For more insight and commentary on these stories, subscribe to the This Week in Cardiology podcast on Apple Podcasts, Spotify, or your preferred podcast provider...

Magnesium Claims for BP; S3 Ultra's Higher Gradients; Antiplatelets Flop in COVID
https://www.medpagetoday.com/cardiology/prevention/96729

Jan 18th, 2022 - Participants in the Framingham Study showed an increased lifetime risk of heart failure from 1965-1989 to 1990-2014. (Journal of the American College of Cardiology) A history of recent COVID-19 may warrant additional preoperative cardiac assessmen...

Jan 7, 2021 This Week in Cardiology Podcast
https://www.medscape.com/viewarticle/966213

Jan 7th, 2022 - Please note that the text below is not a full transcript and has not been copyedited. For more insight and commentary on these stories, subscribe to the This Week in Cardiology podcast on Apple Podcasts, Spotify, or your preferred podcast provider...

Heart Transplant After Severe COVID; Patients Stuck With HVAD; ICH Triggers
https://www.medpagetoday.com/cardiology/prevention/96331

Dec 21st, 2021 - A Brazilian man successfully received a heart transplant while still hospitalized with severe COVID-19 illness. (U.S. News) People with secondary prevention implantable cardioverter-defibrillators had appropriate shocks happen rarely after 3 month...

Industry Payments Go Mostly to KOLs -- Does It Matter?
https://www.medscape.com/viewarticle/940166

Nov 4th, 2020 - This transcript has been edited for clarity. Welcome to Impact Factor, your weekly dose of commentary on a new medical study. I'm Dr F. Perry Wilson from the Yale School of Medicine. Doctors, how much money did you receive from industry last year?...

see more →

Patient Education  1 results see all →